Safety Profile Following Td Vaccination in Indonesian Pregnant Woman

Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine in Indonesian Adults, Adolescents, Children and Infants

NCT03460405 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Adults and Children (Phase I)

NCT03109600 ·Status: COMPLETED ·Phase: PHASE1

Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)

NCT04051268 ·Status: COMPLETED ·Phase: PHASE3

A Post-marketing, Observational, Retrospective Study to Assess the Safety of RefortrixTM (Tdap) When Administered During Pregnancy in a Maternal Immunization Program in Brazil.

NCT02757950 ·Status: COMPLETED

Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children ( DTaP/DT )

NCT05870631 ·Status: UNKNOWN ·Phase: PHASE4

Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women

NCT02783170 ·Status: COMPLETED ·Phase: PHASE4

Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in Indonesian

NCT04741828 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Safety of Tetanus, Diphtheria, Acellular Pertussis With 5 Acellular Pertussis Components (Tdap5) Vaccination During Pregnancy

NCT06258057 ·Status: ACTIVE_NOT_RECRUITING

Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9

NCT00489970 ·Status: COMPLETED ·Phase: PHASE3

Pertussis Maternal Immunization Study

NCT00553228 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

The Safety of Boostrix Following Routine Immunization of Pregnant Women

NCT03463577 ·Status: COMPLETED

Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children

NCT05870618 ·Status: UNKNOWN ·Phase: PHASE4

Immune Response followingTdap Vaccine in Pregnancy

NCT04082299 ·Status: COMPLETED

A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine

NCT00109330 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia

NCT03188458 ·Status: TERMINATED ·Phase: PHASE4

A Study to Describe the Safety Profile and Compare the Immune Response of 4 Different Formulations of an Investigational Tdap Vaccine When Compared to Licensed Tdap Vaccine in Young Adults in Canada

NCT03958799 ·Status: COMPLETED ·Phase: PHASE1

To Evaluate the Immunogenicity and Safety of 'BR-TD-1001' Administered Intramuscularly in Healthy Children

NCT04618939 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine

NCT02813486 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents

NCT02118961 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058

NCT00548171 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Boostrix Vaccine Administered as a Booster Dose in Healthy Russian Subjects

NCT03311659 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine

NCT00635128 ·Status: COMPLETED ·Phase: PHASE4

Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose

NCT03999996 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria.

NCT05480462 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents

NCT01362322 ·Status: COMPLETED ·Phase: PHASE4